Analytical Data
-
Gene name
NPTN
- Application
-
Alternative Names
SDR1; GP55; GP65; SDFR1; np55; np65; Stromal Cell Derived Factor Receptor 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y639
-
Expression Region
Thr185~Asn317
-
Molecular Weight
20kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NPTN (Neuroplastin) is a member of the immunoglobulin superfamily and is crucial for various neuronal processes, including synaptic function, cell adhesion, and neuronal survival. Research into NPTN's recombinant protein has gained significant attention due to its potential implications in neurodevelopmental and neurodegenerative disorders. It is highly expressed in the brain and plays a role in the modulation of neurotransmitter signaling. Abnormalities in NPTN expression have been associated with conditions such as schizophrenia and autism, making it a key target for therapeutic interventions. Understanding the structure and function of NPTN through recombinant protein studies can provide insights into its biological roles and molecular mechanisms. Furthermore, recombinant NPTN can be used to develop new diagnostic tools and treatment strategies aimed at restoring normal neuronal function. As the need for novel therapies for neuropsychiatric disorders increases, ongoing studies on NPTN and its recombinant forms are crucial for advancing our knowledge of brain health and disease.
